Corvus Pharmaceuticals, Inc.
Pharmaceutical formulations
Last updated:
Abstract:
The disclosure provides, inter alia, pharmaceutical compositions comprising micronized drug particles of adenosine A2A receptor antagonists, and methods of treating cancer using the pharmaceutical compositions.
Status:
Grant
Type:
Utility
Filling date:
1 Feb 2019
Issue date:
8 Mar 2022